Analyst Ratings For Albemarle
Portfolio Pulse from Benzinga Insights
Analysts have provided mixed reviews on Albemarle (NYSE:ALB) over the past three months, with recent sentiment shifting negatively. The average 12-month price target has been reduced by 19.97% to $171.67. Analysts from firms including UBS, Deutsche Bank, Keybanc, B of A Securities, Piper Sandler, BMO Capital, RBC Capital, and Oppenheimer have adjusted their ratings and price targets, mostly lowering them. Albemarle is a major lithium producer with strong market presence, revenue growth, net margin, ROE, and ROA, and a healthy debt-to-equity ratio.
January 11, 2024 | 7:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Albemarle has received varied ratings from analysts, with a general decrease in price targets, indicating a bearish short-term outlook despite strong financial indicators.
The reduction in price targets by multiple analysts suggests a bearish sentiment that could negatively affect investor confidence and the stock price in the short term. However, the company's strong financial performance may mitigate some of the negative impact.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100